ID
TCRT icon

Integral Derivatives’s Alaunos Therapeutics TCRT Stock Holding History

Integral Derivatives’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$338K Sell
574
-1,028
-64% -$641K 0.01% 486
2017
Q4 		$995K Buy
1,602
+828
+107% +$595K 0.02% 483
2017
Q3 		$713K Buy
774
+407
+111% +$362K 0.01% 617
2017
Q2 		$343K Buy
+367
New +$360K 0.01% 823
2017
Q1 		– Sell
-98
Closed -$79K – 1359
2016
Q4 		$79K Buy
98
+7
+8% +$6.31K ﹤0.01% 1075
2016
Q3 		$77K Buy
+91
New +$73.1K ﹤0.01% 954
2014
Q4 		– Sell
-177
Closed -$70K – 1553
2014
Q3 		$70K Hold
177
– – ﹤0.01% 1350
2014
Q2 		$107K Hold
177
– – ﹤0.01% 1269
2014
Q1 		$121K Buy
+177
New +$119K ﹤0.01% 1218

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return